Backlash over ritonavir  price hike.
On December 3, 2003, Abbott Laboratories, the pharmaceutical company that makes lopinavir (Kaletra), announced that it was going to raise the price of its other anti-HIV drug, ritonavir (Norvir), from $2.14 to $10.72 per capsule in the U.S.--an increase of 400%. (These prices reflect the Average Wholesale Price, or AWP, a national average of list prices charged by wholesalers to pharmacies.)
Huff
Bob
B
D016527:Drug Costs / Q000639:trends*; D004345:Drug Industry / Q000191:economics / Q000458:organization & administration*; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000191:economics*; D006801:Humans; D019438:Ritonavir / Q000008:administration & dosage / Q000191:economics*; D014481:United States
D017320:HIV Protease Inhibitors; D019438:Ritonavir